A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.

NCT03628079 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of effect

Conditions

Cancer of the Gastrointestinal Tract
Cancer of Unknown Origin

Interventions

DRUG: ReposMBZ

Sponsor

Repos Pharma

Collaborators

[object Object]
[object Object]